ENDO Preview

Sriram Gubbi of NIDDK Wins Endocrine Society’s 2025 Endocrine Images Art Competition

“Cosmic Bubble” image features cells from a thyroid cancer subtype Sriram Gubbi, MD, won the Endocrine Society’s 2025 Endocrine Images Art Competition with his microphotograph of follicular thyroid carcinoma cells titled “The Cosmic Bubble”. The art competition celebrates the beauty of endocrine science as seen through the lens of a microscope. More than 30 entries...

Weighing In: Making Obesity Treatment More Effective and Accessible by 2030

Endocrine News speaks to the participants of the ENDO 2025 symposium “Future Developments and Challenges in Obesity Treatment: Where Will We Stand at ENDO 2030?” who discuss the future of treating this formidable condition. This July, the year’s biggest event in endocrinology happens in San Francisco, Calif. Although every ENDO is special, ENDO 2025...

Harsh Realities: How Treating Obesity Across the Lifespan Continues to Evolve

Fatima Cody Stanford, MD, MPH, MPA, MBA, takes the lessons she learned growing up in Atlanta serving her community and applies them to her work treating obesity. In July, she’ll give the plenary presentation at ENDO 2025, “Changing the Game of Obesity Care Across Lifespan: Policies, Diets, and Drug Innovation,” offering attendees a comprehensive overview...

ENDO Preview

New Professional Development Workshops Debut at ENDO 2024

What do podcasting, grant writing, microaggressions, and retirement all have in common? They are all topics covered by new Professional Development Workshops at ENDO 2024! When attendees descend on Boston in June for ENDO 2024, they will have the opportunity to participate in a series of workshops that will enhance their visibility in the endocrine...

Advancements from Atumelnant (CRN04894) and Paltusotine Development Programs to Be Presented at ENDO 2024

Five abstracts from Crinetics Pharmaceuticals’s clinical development programs, including four late-breaking abstracts, will be presented at the Endocrine Society’s annual meeting, ENDO 2024, taking place June 1-4, 2024 in Boston – including initial data from a Phase 2 Trial of atumelnant in congenital adrenal hyperplasia (CAH). “This year’s Endocrine Society meeting represents a major milestone for...

ENDO Preview

Cheers to Boston!

As the Endocrine Society prepares to welcome the endocrinology world to Boston from ENDO 2024, Endocrine News is once again highlighting our host city’s local flair, with some conference highlights as well. Plus, we’ve got recommendations from some of your in-the-know colleagues! Boston may be one of America’s most historic cities, but it’s far from...

Pandora’s Box? How Artificial Intelligence Could Impact Endocrinology

Like it or not, artificial intelligence (AI) is here to stay, and its impact on both the science and practice of endocrinology will soon be quite evident. The ENDO 2024 Plenary session, “Artificial Intelligence in Health and Biomedical Research: The Future Is Now,” will no doubt answer many questions on the minds of endocrinologists in...

ENDO Preview

In Harm’s Way: New Research Elucidates the Never-Ending Impacts of Endocrine-Disrupting Chemicals

Science has shown that virtually all of us are exposed to endocrine-disrupting chemicals (EDCs) essentially as soon as we’re born … and even before! The ENDO 2024 symposium “Endocrine-Disrupting Chemicals in Reproductive Endocrinology” looks at these impacts in three different sessions that look at EDCs prenatally, postnatally, and environmentally. When you head to Boston, Mass.,...

ENDO Preview

Endocrine news on twitter